Suppression of autophagy enhanced growth inhibition and apoptosis of interferon-β in human glioma cells

Molecular Neurobiology

Volumn 47, Issue 3, 2013, Pages 1000-1010

  Li, Yubin ^a,b   Zhu, Haiyan ^a   Zeng, Xian ^a   Fan, Jiajun ^a   Qian, Xiaolu ^c   Wang, Shaofei ^a   Wang, Ziyu ^a   Sun, Yun ^a   Wang, Xiaodan ^d   Wang, Weiwu ^b   Ju, Dianwen ^a  

^a FUDAN UNIVERSITY   (China)

^b AGRO ENVIRONMENTAL PROTECTION INSTITUTE   (China)

^c NANJING AGRICULTURAL UNIVERSITY   (China)

^d TONGJI UNIVERSITY   (China)

Author keywords

Autophagy; Glioma cells; Growth; IFN ; Inhibition Apoptosis

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 3 METHYLADENINE; BETA INTERFERON; CASPASE; CHLOROQUINE; LIGHT CHAIN 3; MAMMALIAN TARGET OF RAPAMYCIN; MICROTUBULE ASSOCIATED PROTEIN 1; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; UNCLASSIFIED DRUG; MTOR PROTEIN, HUMAN; TARGET OF RAPAMYCIN KINASE;

APOPTOSIS; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; CELL GROWTH; CELL PROLIFERATION ASSAY; CONTROLLED STUDY; DOSE RESPONSE; ENZYME INHIBITION; GLIOMA; GLIOMA CELL; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; CELL PROLIFERATION; DRUG EFFECT; ENZYMOLOGY; METABOLISM; PATHOLOGY; PHAGOSOME; TUMOR CELL LINE; ULTRASTRUCTURE;

APOPTOSIS; AUTOPHAGY; CELL LINE, TUMOR; CELL PROLIFERATION; GLIOMA; HUMANS; INTERFERON-BETA; MAP KINASE SIGNALING SYSTEM; PHAGOSOMES; PROTO-ONCOGENE PROTEINS C-AKT; TOR SERINE-THREONINE KINASES;

EID: 84887270621     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-013-8403-0     Document Type: Article

References (43)

1. Natsume A, Ishii D, Wakabayashi T., Tsuno T, Hatano H, Mizuno M., Yoshida J. (2005) IFN-beta down-regulates the expression of DNA repair gene MGMT and sensitizes resistant glioma cells to temozolomide. Cancer Res 65(17):7573-7579. doi:10.1158/0008-5472.CAN-05-0036
2. Stewart LA (2002) Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet 359(9311):1011-1018
3. Okazaki T, Kageji T, Kuwayama K., Kitazato KT, Mure H, Hara K, Morigaki R., Mizobuchi Y, Matsuzaki K, Nagahiro S (2012) Up-regulation of endogenous PML induced by a combination of interferon-beta and temozolomide enhances p73/YAP-mediated apoptosis in glioblastoma. Cancer Lett 323(2):199-207. doi:10.1016/j.canlet.2012.04.013
4. Auffinger B, Thaci B, Nigam P., Rincon E, Cheng Y, Lesniak M.S. (2012) New therapeutic approaches for malignant glioma: in search of the Rosetta stone. F1000 Med Rep 4:18. doi:10.3410/M4-18
5. Natsume A, Wakabayashi T, Ishii D., Maruta H, Fujii M, Shimato S., Ito M, Yoshida J (2008) A combination of IFN-beta and temo-zolomide in human glioma xenograft models: implication of p53-mediated MGMT downregulation. Cancer Chemother Pharmacol 61(4):653-659. doi:10.1007/s00280-007-0520-x
6. Saito R, Mizuno M, Hatano M., Kumabe T, Yoshimoto T, Yoshida J. (2004) Two different mechanisms of apoptosis resistance observed in interferon-beta induced apoptosis of human glioma cells. J Neurooncol 67(3):273-280
7. Yoshino A, Ogino A, Yachi K., Ohta T, Fukushima T, Watanabe T., Katayama Y, Okamoto Y, Naruse N, Sano E (2009) Effect of IFN-beta on human glioma cell lines with temozolomide resistance. Int J Oncol 35(1):139-148
8. Mahoney E, Lucas DM, Gupta S.V., Wagner AJ, Herman SE, Smith LL, Yeh Y.Y., Andritsos L., Jones JA, Flynn JM, Blum KA, Zhang X, Lehman A, Kong H, Gurcan M, Grever MR, Johnson AJ, Byrd JC (2012) ER stress and autophagy: new discoveries in the mechanism of action and drug resistance of the cyclin-dependent kinase inhibitor flavopiridol. Blood 120(6):1262-1273. doi:10.1182/blood-2011-12-400184
9. Zou Z, Yuan Z, Zhang Q, Long Z, Chen J, Tang Z, Zhu Y, Chen S, Xu J, Yan M, Wang J, Liu Q (2012) Aurora kinase A inhibition-induced autophagy triggers drug resistance in breast cancer cells. Autophagy 8(12):1798-810. doi:10.4161/auto.22110
10. Levine B, Kroemer G. (2008) Autophagy in the pathogenesis of disease. Cell 132(1):27-42. doi:10.1016/j.cell.2007.12.018
11. Mizushima N (2007) Autophagy: process and function. Genes Dev 21(22):2861-2873. doi:10.1101/gad.1599207
12. Corradetti MN, Guan K.L. (2006) Upstream of the mammalian target of rapamycin: do all roads pass through mTOR? Oncogene 25(48):6347-6360. doi:10.1038/sj.onc.1209885
13. He C, Klionsky D.J. (2009) Regulation mechanisms and signaling pathways of autophagy. Annu Rev Genet 43:67-93. doi:10.1146/annurev-genet-102808-114910
14. Shintani T, Klionsky D.J. (2004) Autophagy in health and disease: a double-edged sword. Science 306(5698):990-995. doi:10.1126/science.1099993
15. White E, DiPaola R.S. (2009) The double-edged sword of autoph-agy modulation in cancer. Clin Cancer Res 15(17):5308-5316. doi:10.1158/1078-0432. CCR-07-5023
16. Kroemer G, Levine B. (2008) Autophagic cell death: the story of a misnomer. Nat Rev Mol Cell Biol 9(12):1004-1010. doi:10.1038/nrm2529
17. Madeo F, Tavernarakis N, Kroemer G. (2010) Can autophagy promote longevity? Nat Cell Biol 12(9):842-846. doi:10.1038/ncb0910-842
18. Marino G, Madeo F, Kroemer G. (2011) Autophagy for tissue homeostasis and neuroprotection. Curr Opin Cell Biol 23(2):198-206. doi:10.1016/j.ceb.2010.10. 001
19. Michallet AS, Mondiere P, Taillardet M., Leverrier Y, Genestier L, Defrance T. (2011) Compromising the unfolded protein response induces autophagy-mediated cell death in multiple myeloma cells. PLoS One 6(10):e25820. doi:10.1371/journal.pone.0025820
20. Chan LL, Shen D, Wilkinson A.R., Patton W., Lai N, Chan E, Kuksin D., Lin B, Qiu J (2012) A novel image-based cytometry method for autophagy detection in living cells. Autophagy 8(9):1371-1382. doi:10.4161/auto.21028
21. Seglen PO, Gordon P.B. (1982) 3-Methyladenine: specific inhibitor of autophagic/lysosomal protein degradation in isolated rat hepa-tocytes. Proc Natl Acad Sci U S A 79(6):1889-1892
22. Pliyev BK, Menshikov M. (2012) Differential effects of the autoph-agy inhibitors 3-methyladenine and chloroquine on spontaneous and TNF-alpha-induced neutrophil apoptosis. Apoptosis 17(10):1050-1065. doi:10.1007/s10495-012-0738-x
23. Kumar S (2007) Caspase function in programmed cell death. Cell Death Differ 14(1):32-43. doi:10.1038/sj.cdd.4402060
24. Hanahan D, Weinberg R.A. (2000) The hallmarks of cancer. Cell 100(1):57-70
25. Guertin DA, Sabatini D.M. (2007) Defining the role of mTOR in cancer. Cancer Cell 12(1):9-22. doi:10.1016/j.ccr.2007.05.008
26. Takeuchi H, Kondo Y, Fujiwara K., Kanzawa T, Aoki H, Mills G.B., Kondo S. (2005) Synergistic augmentation of rapamycin-induced autophagy in malignant glioma cells by phosphatidylinositol 3-kinase/protein kinase B inhibitors. Cancer Res 65(8):3336-3346. doi:10.1158/0008-5472.CAN-04-3640
27. Jung CH, Ro SH, Cao J, Otto N.M., Kim D.H. (2010) mTOR regulation of autophagy. FEBS Lett 584(7):1287-1295. doi:10.1016/j.febslet.2010.01.017
28. Ogier-Denis E., Pattingre S, El Benna J, Codogno P. (2000) Erk1/2-dependent phosphorylation of Galpha-interacting protein stimulates its GTPase accelerating activity and autophagy in human colon cancer cells. J Biol Chem 275(50):39090-39095. doi:10.1074/jbc.M006198200
29. Pattingre S, Bauvy C, Codogno P. (2003) Amino acids interfere with the ERK1/2-dependent control of macroautophagy by controlling the activation of Raf-1 in human colon cancer HT-29 cells. J Biol Chem 278(19):16667-16674. doi:10.1074/jbc.M210998200
30. Cagnol S, Chambard J.C. (2010) ERK and cell death: mechanisms of ERK-induced cell death-apoptosis, autophagy and senescence. FEBS J 277(1):2-21. doi:10.1111/j.1742-4658.2009.07366.x
31. Park MY, Kim DR, Jung H.W., Yoon HI, Lee JH, Lee C.T. (2010) Genetic immunotherapy of lung cancer using conditionally replicating adenovirus and adenovirus-interferon-beta. Cancer Gene Ther 17(5):356-364. doi:10.1038/cgt. 2009.78
32. Vitale G, Zappavigna S, Marra M., Dicitore A, Meschini S, Condello M., Arancia G, Castiglioni S, Maroni P, Bendinelli P, Piccoletti R, van Koetsveld PM, Cavagnini F, Budillon A, Abbruzzese A, Hofland LJ, Caraglia M (2012) The PPAR-gamma agonist troglitazone antagonizes survival pathways induced by STAT-3 in recombinant interferon-beta treated pancreatic cancer cells. Biotechnol Adv 30(1):169-184. doi:10.1016/j.biotechadv.2011.08.001
33. Olson MV, Lee J, Zhang F., Wang A, Dong Z. (2006) Inducible nitric oxide synthase activity is essential for inhibition of prostatic tumor growth by interferon-beta gene therapy. Cancer Gene Ther 13(7):676-685. doi:10.1038/sj.cgt.7700941
34. Paty DW, Li D.K. (1993) Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group. Neurology 43(4):662-667
35. Ruotsalainen J, Martikainen M, Niittykoski M., Huhtala T, Aaltonen T, Heikkila J., Bell J, Vaha-Koskela M, Hinkkanen A (2012) Interferon-beta sensitivity of tumor cells correlates with poor response to VA7 virotherapy in mouse glioma models. Mol Ther 20(8):1529-1539. doi:10.1038/mt.2012.53
36. Paillas S, Causse A, Marzi L., de Medina P, Poirot M, Denis V., Vezzio-Vie N, Espert L, Arzouk H, Coquelle A, Martineau P, Del Rio M, Pattingre S, Gongora C (2012) MAPK14/p38alpha confers irinotecan resistance to TP53-defective cells by inducing survival autophagy. Autophagy 8(7):1098-112. doi:10.4161/auto.20268
37. Kong D, Ma S, Liang B., Yi H, Zhao Y, Xin R., Cui L, Jia L, Liu X (2012) The different regulatory effects of p53 status on multidrug resistance are determined by autophagy in ovarian cancer cells. Biomed Pharmacother 66(4):271-278. doi:10.1016/j.biopha.2011.12.002
38. Sun J, Desai MM, Soong L, Ou J.H. (2011) IFN-alpha/beta and autophagy: tug-of-war between HCV and the host. Autophagy 7(11):1394-1396. doi:10.4161/auto.7.11.17514
39. Desai MM, Gong B, Chan T., Davey RA, Soong L, Kolokoltsov AA, Sun J. (2011) Differential, type I interferon-mediated autophagic trafficking of hepatitis C virus proteins in mouse liver. Gastroenterology 141(2):674-685. doi:10.1053/j.gastro.2011.04.060, 685 e671-676
40. Liang C (2010) Negative regulation of autophagy. Cell Death Differ 17(12):1807-1815. doi:10.1038/cdd.2010.115
41. Lomonaco SL, Finniss S, Xiang C., Lee HK, Jiang W, Lemke N, Rempel S.A., Mikkelsen T., Brodie C. (2011) Cilengitide induces autophagy-mediated cell death in glioma cells. Neuro Oncol 13(8):857-865. doi:10.1093/neuonc/nor073
42. Kondo Y, Kanzawa T, Sawaya R., Kondo S. (2005) The role of autophagy in cancer development and response to therapy. Nat Rev Cancer 5(9):726-734. doi:10.1038/nrc1692
43. Sivaprasad U, Basu A. (2008) Inhibition of ERK attenuates autoph-agy and potentiates tumour necrosis factor-alpha-induced cell death in MCF-7 cells. J Cell Mol Med 12(4):1265-1271. doi:10.1111/j.1582-4934.2008.00282.x